Nosocomial transmission of HCV is a concern in haemodialysis (HD) units worldwide. Diagnosis of HCV infection among dialysis patients is currently based on the detection of anti HCV antibodies by ELISA, and is confirmed by HCV RNA. The average window period between HCV infection and seroconversion with new generations of HCV antibody tests remains approximately 70 days with more prolonged period among dialysis patients. In this study we assessed the diagnostic performance of an immunoassay designed for simultaneous detection of anti HCV antibodies and core antigen in one step in comparison to qualitative RT-PCR and anti HCV antibodies detection test among Egyptian haemodialysis patients. The studied patients were 39 chronic renal failure patients on maintenance haemodialysis. The results obtained in the present study revealed HCV infection of 56.4%. Combined Ag/Ab test detected 3 out of the 4 anti-HCV negative viraemic patients who were in the window period. The sensitivity, specificity and accuracy of the test were higher than that of anti HCV antibodies detection test (95.45%, 94.1% and 94.87% versus 81.8%, 88.23% and 84.6%) and they were raised to 100% on combining its positivity with liver enzymes elevation results. Therefore, this simple combined Ag/Ab test can be applied for early detection of HCV infection during window period among HD patients as an alternative to HCV RNA detection.
INTRODUCTION
The hepatitis C virus (HCV) is a prevalent infectious disease generally contracted via HCV infected blood and blood products (33) . Egypt has the highest seroprevalence for HCV with rates up to 20% in some areas. The high rate of HCV transmission continues both iatrogenically and within the community (11) .
Nosocomial transmission of HCV is a concern in haemodialysis (HD) units worldwide (2, 6, 13, 31) . In these patients, blood transfusions and long term dialysis are risk factors for transmission of HCV (28) Prompt assessment of devovo HCV among dialysis patients is required to limit nosocomial spread of HCV (12) . Routine
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Detection of HCV core antigen and antibodies testing for alanine amino transferase (ALT) and HCV RNA are recommended by CDC for anti-HCV negative patients (9) .
Different generations of anti HCV antibody assays have been developed with improved performance that reduce the risk of HCV transmission by reducing the window period from 82 (7) to 66 days with later generation assays (5, 10) .
To prevent transmission of HCV during the window period before seroconversion, nucleic acid amplification technology (NAT) has been developed that include polymerase chain reaction (PCR), transcription mediated amplification (TMA) (26) , and signal amplification [branched chain DNA (bDNA)] (32). However, such techniques are expensive, may give false positive or negative results (12), could not totally prevent HCV transmission and anti HCV screening must be combined (8, 18, 25) .
Some studies indicate that HCV core antigen can be detected in the window period before seroconversion and HCV core antigen levels correlate well with HCV RNA levels (4, 24, 29 ). An immunoassay based on the simultaneous detection of HCV core Ag. and antibodies has been developed (19) .
The aim of the present study is to assess the diagnostic performance of this assay for early detection of HCV infection during the window period among haemodialysis patients in comparison to anti HCV antibodies and HCV RNA detection tests. together with anti-core monoclonal antibodies was added which in turn bound to the reagents on the wells.
MATERIALS AND METHODS

Subjects
In reactive wells, addition of substrate solution containing 3,3`, 5,5` tetramethylbenzidine (TMB) and hydrogen peroxide gave a blue green color which was converted to an orange color when the reaction was stopped with 1N sulphuric acid.
Samples with absorbance greater than or equal to the cut off were considered reactive while samples with absorbance lower than the cutoff value were negative.
RT-PCR
RNA was isolated using QIA amp viral RNA mini kit (Cat # 52904). Frozen sera were thawed immediately before use. 
Statistical analysis
Data entry and analyses were performed using SPSS statistical package version 10 (SPSS, Inc., Chicago, IL, USA).
Qualitative data were expressed as numbers and percentages.
Sensitivity, specificity and accuracy of tests were carried out using standard equations.
RESULTS
The studied population represented 39 Egyptian chronic renal failure patients. Routine anti -HCV antibody detection is not applicable to confirm HCV infection during early period before anti-HCV antibody has been produced (27) , particularly in HD patients who fail to produce rapid strong immune response and have a prolonged serological window phase after a recent HCV infection (28) . Moreover, occult HCV infection may be common among these patients (30) .
HCV RNA assay is difficult and lacks reproducibility which limited its application in the early clinical diagnosis and screening (14) . The detection of HCV antigen enables the diagnosis of HCV in the preconversion phase, but its high cost prevents its application in developing countries (33) . 
